Zacks Investment Research
10 Aug 2026, 22:56 UTC · 1d ago
ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
10 Aug 2026, 22:56 UTC · 1d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ProKidney Corp. (PROK) reported a quarterly loss of $0.15 per share, missing the consensus estimate of $0.13. — Earnings misses typically trigger negative price action due to underperformance against analyst expectations.
-0.40ProKidney Corp. quarterly revenues were $0.15 million, missing the consensus estimate by 31.82%. — A significant revenue miss indicates weakening top-line growth and business momentum.
-0.40ProKidney Corp. has surpassed consensus EPS estimates only once over the last four quarters. — A pattern of consistent earnings misses suggests systemic operational struggles or overly optimistic forecasting.
-0.20Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company reported a quarterly loss that exceeded analyst estimates and missed revenue expectations significantly.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
2h ago
